An upcoming U.S. congressional visit to China is unlikely to generate tangible gains other than potentially opening the door to further visits, as many constraints remain on even limited U.S.-China cooperation. Confirming media reports first aired in September, Senate Majority Leader Chuck Schumer (D-NY) and the ranking Republican on the Senate Finance Committee, Mike Crapo (R-ID), plan to lead a delegation to China next week that will include four other U.S. senators from both parties. The delegation aims to meet with President Xi Jinping, according to a spokesperson for Crapo. Schumer's office claimed the trip would also involve discussions on China's treatment of U.S. companies, human rights issues and the illicit fentanyl trade. Numerous news outlets have further highlighted that Schumer and Crapo plan to specifically discuss Beijing's treatment of U.S. memory chipmaker Micron, on which China placed purchasing restrictions in May in what appeared to be retaliation for U.S....
